Moreover, this patient's epilepsy was treated very aggressively with high doses of PLP for the first 14 years of his life and so he was protected from secondary epileptogenesis due to processes such as gliosis/neuronal damage because of untreated PLP deficiency/seizures. The gene discussed is PLP1; the disease is epilepsy.